drugset / Trial / NCT04131192
Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
This phase IB trial is studying how well giving gemcitabine together with Z650 works in treating patients with metastatic or recurrent pancreatic cancer.
Timeline
- Start
- 2019-11-11
- Primary completion
- 2021-09-09
- Completion
- 2021-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |
| Subject | Larotinib | Unknown | 200 mg | — |
| Subject | Larotinib | Unknown | 250 mg | — |
| Subject | Larotinib | Unknown | 300 mg | — |